Philips Acquires SpectraWAVE, WHO Calls for AI Standards, and OpenEvidence Hits $12B Valuation - Life AI Weekly #46
December 17, 2025 -
Life AI Weekly
Hi there,
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we explore a range of exciting developments, including Philips' strategic move to acquire SpectraWAVE Inc. to bolster its AI capabilities in coronary imaging, and the Human Phenotype Project's innovative use of AI to deepen our understanding of complex diseases. Additionally, Chai Discovery has made headlines by raising $130 million to further its AI-driven molecule design platform, while researchers at KAIST have developed a promising AI-based nasal antiviral platform.
In other news, Jutro Medical has secured significant funding to expand its AI healthcare services, and Mass General Brigham has launched AIwithCare to enhance clinical trial processes. The World Health Organization is calling for clear AI liability standards in healthcare, emphasizing the importance of accountability as AI technologies become more prevalent. These stories, among others, highlight the transformative potential of AI in revolutionizing healthcare and improving patient outcomes. Stay tuned for more insights and updates!
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we explore a range of exciting developments, including Philips' strategic move to acquire SpectraWAVE Inc. to bolster its AI capabilities in coronary imaging, and the Human Phenotype Project's innovative use of AI to deepen our understanding of complex diseases. Additionally, Chai Discovery has made headlines by raising $130 million to further its AI-driven molecule design platform, while researchers at KAIST have developed a promising AI-based nasal antiviral platform.
In other news, Jutro Medical has secured significant funding to expand its AI healthcare services, and Mass General Brigham has launched AIwithCare to enhance clinical trial processes. The World Health Organization is calling for clear AI liability standards in healthcare, emphasizing the importance of accountability as AI technologies become more prevalent. These stories, among others, highlight the transformative potential of AI in revolutionizing healthcare and improving patient outcomes. Stay tuned for more insights and updates!
Philips to Acquire SpectraWAVE for AI Coronary Imaging
Dutch health technology company Philips has announced its agreement to acquire SpectraWAVE Inc. to integrate AI-powered vascular imaging technologies into its portfolio, enhancing coronary artery disease treatment. Read more
Human Phenotype Project Uses AI for Disease Understanding
The Human Phenotype Project is utilizing deep phenotyping and generative AI to enhance the understanding of complex diseases, aiming to improve early detection and precision healthcare. Read more
Chai Discovery Raises $130 Million for AI Molecule Design
Chai Discovery, supported by OpenAI, has secured $130 million in Series B funding to enhance its AI-driven platform for designing life-saving medicines. The company is now valued at $1.3 billion. Read more
KAIST Develops AI-Powered Nasal Antiviral Platform
Researchers at KAIST have created a nasal antiviral platform using AI to improve interferon-lambda treatments for respiratory viruses, including influenza and COVID-19. Read more
Jutro Medical Secures €24M for AI Healthcare Expansion
Warsaw-based startup Jutro Medical has raised €24 million in a Series A extension to enhance its AI-driven primary healthcare services across Poland and Europe. Read more
Mass General Brigham Launches AIwithCare for Clinical Trials
Mass General Brigham has introduced AIwithCare, a generative AI startup designed to improve patient screening for clinical trials using large language models. Read more
Ask Sage Partners with Defense Health Agency for AI Platform
Ask Sage has partnered with the Defense Health Agency to provide a Generative AI platform authorized for processing Protected Health Information, aiming to improve military healthcare operations. Read more
All G and Armor Protéines Form Joint Venture for Lactoferrin Production
Australian startup All G has raised $6.6 million and partnered with French company Armor Protéines to scale the production of human and bovine lactoferrin using precision fermentation. The joint venture plans to launch recombinant bovine lactoferrin by Q1 2026. Read more
WHO Calls for AI Liability Standards in Healthcare
The World Health Organization has urged countries to set clear liability standards for AI in healthcare, highlighting the need for accountability and safety measures as AI adoption grows. Read more
Mindoo Secures €5M for AI Hospital Automation
Belgian startup Mindoo has raised €5M in seed funding to enhance its AI platform for automating hospital intake and administrative tasks, supported by investors including 6DC and Syndicate One. Read more
Latent Labs Reaches Milestone with AI-Generated Antibodies
Latent Labs has achieved a significant milestone in drug development with its AI-generated antibodies showing low immunogenicity in human immune cell assays. This development coincides with the appointment of former Merck KGaA CEO Stefan Oschmann to the advisory board. Read more
PhaseV Reports Record Growth in 2025
PhaseV announced a significant increase in revenue and partnerships in 2025, alongside securing $50 million in Series A funding. The company plans to expand its AI platform in clinical development to improve trial efficiency and patient outcomes. Read more
New Hampshire Proposes AI and Telemedicine Bills
New Hampshire has introduced two bills aimed at regulating the use of artificial intelligence in health insurance and promoting telemedicine. The proposed legislation seeks to prevent insurers from using AI to override doctors' decisions and ensure equal reimbursement for telemedicine services. Read more
OpenEvidence Valuation Hits $12 Billion After Funding
The AI healthcare startup OpenEvidence has reached a valuation of $12 billion following a $250 million equity financing round, highlighting investor confidence in AI healthcare solutions. Read more
Valerie Health Raises $30 Million for AI in Healthcare
Valerie Health has secured $30 million in Series A funding to enhance AI solutions for independent doctors' offices. The funding aims to automate administrative tasks and improve healthcare accessibility. Read more
Leona Health Raises $14M to Improve Doctor-Patient Communication
Leona Health has secured $14 million in seed funding from Andreessen Horowitz to enhance doctor-patient communication via WhatsApp in Latin America. The AI-powered app aims to help doctors manage communications more efficiently across 14 countries and 22 medical specialties. Read more
Everbloom's AI Turns Chicken Feathers into Cashmere-like Material
Everbloom, a startup, has developed an AI called Braid.AI to create an upcycled material from chicken feathers that resembles cashmere. This innovation aims to provide biodegradable and economically viable fibers for the textile industry. Read more
FABP4 and GPT-4 Enhance LRTI Diagnosis
A study in Nature Communications reveals a new method for diagnosing lower respiratory tract infections by integrating the FABP4 biomarker with GPT-4, achieving a 96% accuracy rate. Read more
Regulatory Challenges for AI in Medical Robotics
The publication by WIK examines the regulatory challenges faced by medical robotics under the AI Regulation (No. 535), focusing on the integration with existing Medical Device Regulation and the implications of the AI Act passed in May 2024. Read more
Caris Life Sciences and Genentech Collaborate on Cancer Research
Caris Life Sciences has partnered with Genentech in a multi-year collaboration to discover new therapeutic targets for solid tumors, with potential payments reaching $1.1 billion. Read more
MapLight and SandboxAQ Partner for AI-Driven CNS Therapies
MapLight Therapeutics has partnered with SandboxAQ to develop AI-driven therapies for central nervous system diseases, with a deal valued at up to $200 million. Read more
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
12/17
AllOne Health Acquires Three EAP Providers to Expand National Reach
12/17
UbiSim Adds AI Narrative Analysis to Streamline Nursing Education
12/17
Caris Life Sciences and Genentech Partner on Cancer Target Discovery
12/16
Chai Discovery Raises $130 Million for AI Molecule Design
12/08
Michael J. Fox Foundation Launches Target Validation Program for Parkinson’s Therapies
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
